Breakthrough Pain

23 registered clinical trials studyying Breakthrough Pain — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Paediatric Breakthrough Pain Assessment NCT06790719	University of Southampton	—
Recruiting	Programmed Intermittent Epidural Bolus Compared With Continuous Infusion in Multiparous Women NCT06580327	Holy Family Hospital, Nazareth, Israel	N/A
Recruiting	PIEB Compared With CEI on Breakthrough Pain in Nulliparous Women NCT06494280	Holy Family Hospital, Nazareth, Israel	N/A
Withdrawn	Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement NCT05053308	Seoul National University	N/A
Unknown	A Prospective Pilot Study of a Non-Narcotic Post-Operative Course After Colectomy NCT05200806	University of Vermont	Phase 4
Recruiting	Development of Variable Volume Automated Mandatory Boluses for Patient-controlled Epidural Analgesia During La NCT04011150	KK Women's and Children's Hospital	Phase 3
Withdrawn	Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Exami NCT03809455	UNICANCER	Phase 2
Completed	Quality of Life Study Breakthrough Cancer Pain Treated in Medical Oncology Services (CAVIDIOM) NCT03435120	Angelini Farmacéutica	—
Completed	Quality of Life Study Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative Intent NCT02836379	Angelini Farmacéutica	—
Completed	Quality of Life Study in Patients With Cancer Breakthrough Pain Treated in Palliative Care Units NCT02840500	Angelini Farmacéutica	—
Completed	Patient Controlled Intrathecal Analgesia With Bupivacaine for Chronic Low Back Pain NCT02886286	University Hospitals Cleveland Medical Center	Phase 4
Completed	Procedural Pain in Palliative Care: Prevalence, Intensity and Treatment NCT02437929	Antea Foundation	—
Completed	Analgesic Efficacy of Transmucosal Fentanyl for Breakthrough Pain Caused by Interventional Gastrostomy NCT02869321	Central Hospital, Nancy, France	Phase 4
Active Not Recruiting	Comparison of Regimens MPIB, CIPCEA, PCEA NCT02278601	KK Women's and Children's Hospital	Phase 3
Terminated	An Observational, Non-Interventional Trial to Assess Patient Satisfaction and Safety of Subsys™ Spray. NCT01901718	International Clinical Research Institute	—
Completed	Intranasal Transmucosal Fentanyl Pectin for Breakthrough Cancer Pain in Radiation-induced Oropharyngeal Mucosi NCT02050503	Grupo de Investigación Clínica en Oncología Radioterapia	—
Completed	Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer NCT01842893	Ethypharm	Phase 3
Completed	Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patien NCT00994760	Takeda	—
Terminated	Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tol NCT00842829	Cephalon	Phase 4
Terminated	Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms Whe NCT00387010	Cephalon	Phase 3
Completed	Staccato Fentanyl Single and Multidose PK NCT00402350	Alexza Pharmaceuticals, Inc.	Phase 1
Completed	Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain NCT00236145	Cephalon	Phase 3
Completed	Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP) NCT00236041	Cephalon	Phase 2